Class Action Cases

Join the case to recover your losses. Click "Join this Class Action" above.

Attorneys

AstraZeneca PLC

Join Class Action »

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The National Institute of Allergy and Infectious Diseases (NIAID) released a statement about AstraZeneca’s COVID-19 vaccine on March 23, 2021. According to the statement, “late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial.” The statement added, “The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data.” Based on this news, shares of AstraZeneca fell in intraday trading on March 23, 2021.

Press Release

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against AstraZeneca PLC and Encourages Investors with Losses of $100,000 to Contact the Firm

Los Angeles, March 23, 2021 — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or “the Company”) (NASDAQ: AZN) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The National Institute of Allergy and Infectious Diseases (NIAID) released a statement about AstraZeneca’s COVID-19 vaccine on March 23, 2021. According to the statement, “late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial.” The statement added, “The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data.” Based on this news, shares of AstraZeneca fell in intraday trading on March 23, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.

310-301-3335

info@schallfirm.com

www.schallfirm.com

Cases

  • Drop files here or
    Accepted file types: xls, xlsx, doc, pdf, jpg, jpeg.
    You may redact your account numbers from your uploaded documents. The Schall Law Firm is committed to protecting the privacy of confidential information. Your documents will be securely held in AWS S3 and will only be used as proof of your transactions in connection with this matter.
  • Purchases
    Date Format: MM slash DD slash YYYY
    If fractional shares, please round to the nearest whole number.
  • Sales
    Date Format: MM slash DD slash YYYY
  • By submitting your information, you acknowledge that this form does not create an attorney-client relationship between yourself and The Schall Law Firm. Any information you submit will be maintained as confidential. The Schall Law Firm, in its sole discretion, will contact you if it requires further information from you.